Connect with us

Press Releases

Ocular Science Appoints Kip Crecca to Its Board of Directors

Crecca, a long-time industry commercialization professional, to supply expertise on medical device sales, production, distribution and customer support.




(PRESS RELEASE) EL SEGUNDO, CA — Kip Crecca, vice president of sales, North America at STAAR Surgical has joined the Ocular Science board of directors. The Southern California biotech specializes in developing easy to use ophthalmic products that are cost-effective and promote patient compliance. Crecca’s appointment is designed to lend insight and industry commercialization proficiency to Ocular Science and its affiliated PCAB-accredited 503A compounding pharmacy OSRX, said Ocular Science founder and CEO Anthony Sampietro.

“Our board is composed of the most accomplished medical minds in ophthalmology. With Kip’s arrival, we’re adding nearly two decades of medical device sales expertise,” said Sampietro. “Kip’s skillset ranges from working with surgeons to years of business development that will add a unique perspective to our board. Kip and I have been associates for quite a few years and I’ve watched him emerge as one of the top sales professionals in our industry. It’s exciting to welcome him to our team.”

Crecca spent more than 10 years at Abbott Medical Optics, where, as strategic accounts manager, U.S., he built and directed the organization’s national sales team. Once Abbott was purchased by Johnson & Johnson, Crecca managed their cataract and refractive portfolio across the eastern third of the U.S. In 2018, he became vice president of sales for STAAR Surgical, which designs, develops, manufactures and markets implantable lenses that lessen dependence on glasses and contact lenses.

“Anthony and I worked together at J&J, and I was there when he recognized a need for simple-to-use, affordable ophthalmic products and decided to start his own company (in 2016). I’ve closely followed his tremendous success and sustained year-over-year growth,” says Crecca. “I’m honored to now join the Ocular Science board – an impressive group of luminaries across the eye care industry. I’m excited to share my commercialization and development expertise to help Ocular Science continue its remarkable growth trajectory.”

OSRX, an Ocular Science affiliate, is a 503A compounding pharmacy that compounds 15 customized (OMNI by OSRX) ophthalmic medications that are patient-specific and have been prescribed for surgical vision correction, myopia and glaucoma management. OSRX combines multiple medications into a single bottle to provide patients with improved convenience, simplicity and affordability by reducing dosing complications and high costs associated with traditional multi-drop regimens.



Meet the Next Generation of Smart Glasses

Ray-Ban Meta is now available with a full range of lenses, as a complete pair or edged lens. Prescription orders eligible through select insurance providers, including Eyemed and private pay. The Ray-Ban Meta collection combines iconic design with cutting-edge technology. Capture life’s best moments and livestream to Facebook and Instagram with an upgraded 12 MP camera and five-mic system. Stay connected with hands-free calls and messages. Listen to your favorite tracks through built-in speakers. Spark your creativity, get information and control your glasses with your voice – powered by Meta AI. All while keeping your phone in your pocket. For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular